FIELD: medicine.
SUBSTANCE: invention concerns area of medicine and concerns treatments with application of botulinic toxin. The essence of the invention includes application of a solid, semisolid or liquid composition of botulinic toxin for treatment of the disturbance characterised by spastic strictures of a bladder by means of distribution of a composition of toxin on an external wall of a cylinder which is intended for inflation in a bladder, thus, a cylinder enter into a bladder cavity through the urethra so that the cylinder could be filled by air in a bladder.
EFFECT: advantage of the invention consists to use of a liquid or semisolid composition of botulinic toxin for local treatment of urethra diseases.
5 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIOPREPARATIONS COMPOSITIONS FOR INTRAVESICAL INSTILLATION | 2015 |
|
RU2720991C2 |
| IMPROVED BLADDER INJECTION SCHEME FOR ADMINISTRATION OF BOTULINUM TOXINS | 2017 |
|
RU2741966C2 |
| LIQUID COMPOSITION OF NEUROTOXIN STABILIZED WITH TRYPTOPHAN OR TYROSINE | 2017 |
|
RU2741497C2 |
| CLOSTRIDIAL NEUROTOXINS WITH MODIFIED PERSISTENCE | 2009 |
|
RU2524429C2 |
| METHODS OF TREATING CHRONIC NEUROGENIC INFLAMMATION BY MODIFIED CLOSTRIDIAL TOXIN | 2010 |
|
RU2568844C2 |
| HIGH INTRODUCTION RATE OF NEUROTOXIC COMPONENT OF BOTULINUM TOXIN | 2007 |
|
RU2453333C2 |
| METHODS OF TREATING INCONTINENCE ASSOCIATED WITH SEXUAL ACTIVITY | 2012 |
|
RU2578475C2 |
| DEVICES AND METHOD TO PRODUCE HIGHLY CLEANED NEUROTOXINS | 2010 |
|
RU2571212C2 |
| PROLONGED-RELEASE PHARMACEUTICAL COMPOSITIONS CONTAINING POLOXAMER | 2009 |
|
RU2482874C2 |
| METHOD OF TREATING THE NEUROGENIC BLADDER | 2020 |
|
RU2743805C1 |
